Norketotifen is under clinical development by Emergo Therapeutics and currently in Phase I for Chronic Fatigue Syndrome (Myalgic Encephalomyelitis). According to GlobalData, Phase I drugs for Chronic ...
In 2021, the National Institute for Health and Care Excellence produced an evidence-based guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a ...
Finally, though, Dr. Shepherd received a diagnosis that not only changed his life, but also led him to help others dealing with the same issue: myalgic encephalomyelitis/chronic fatigue syndrome ...